In a statement released on Friday, Microsoft’s Xbox chief Phil Spencer said that the company was “unequivocally wrong” in hiring go-go dancers for...
A team of medical experts in Brazil has tested a new dengue vaccine, which was successful in alleviating the disease.
Local media reported that the new vaccine has been successful in alleviating the disease. The vaccine, developed by French pharmaceutical firm Sanofi Pasteur, is believed to be the first developed dengue vaccine in the world. Experts said that the new vaccine passed all study and test trials.
The vaccine was effective in reducing severe cases of the disease about 95.5 percent of the time during its testing in Brazil and Latin America. Sheila Homsani, the firm's vaccines division, has said that the new vaccine is safe and will be able to reduce the number of dengue patients that will require treatment in hospitals. The vaccine needs to be applied three times after six month intervals.
Dengue is a recurrent problem in the country especially during rainy summers. Dengue outbreaks occur in different parts of the country. Experts said that about 377 people had died from dengue fever in Brazil up to the first week of October and 547,600 cases have been reported nationwide. The situation has improved since the previous year. The disease is common in Central and South American nations.